Skip to content
type1.science
Phase 1RecruitingNCT07503028

Celregen CRG-002 allogeneic iPSC-derived islets

Exploratory early-phase study of allogeneic iPSC-derived pancreatic islet cells given by portal-vein infusion or anterior rectus sheath transplantation in diabetes with hypoglycemia unawareness or severe events.

Primary endpoints

  • Safety assessed by adverse events according to CTCAE v6.0

Results so far

No results posted yet.